Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:96:100667.
doi: 10.1016/j.curtheres.2022.100667. Epub 2022 Mar 30.

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy

Affiliations

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy

Mary Beth Yacyshyn et al. Curr Ther Res Clin Exp. 2022.
No abstract available

Keywords: Bismuth subsalicylate (BSS); SARS-CoV-2; helicase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
SARS-CoV-2 status on day 3 versus baseline health and medication status. (A) Baseline health scores. Baseline health scores were calculated by using the sum of the number of preexisting comorbidities + the number of baseline COVID–19-related 5 symptoms + number of COVID-19 morbidities. (B) The number of any existing home medications that patients were taking. Open symbols represent outpatients and closed symbols represent inpatients. Statistics were performed using Prism 9 for Mac OS (GraphPad Software, San Diego, California). Nonparametric Mann-Whitney P values were reported.

References

    1. Ledford H. COVID antiviral pills: what scientists still want to know. Nature. 2021 Nov;599(7885):358–359. doi: 10.1038/d41586-021-03074-5. PMID: 34759341. - DOI - PubMed
    1. Gandhi M. The new COVID drugs are a bigger deal than people realize. Accessed March 29, 2022. https://www.theatlantic.com/ideas/archive/2021/11/covid-drugs-molnupirav....
    1. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 Jul;583(7816):459–468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30. PMID: 32353859; PMCID: PMC7431030. - DOI - PMC - PubMed
    1. Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MÁ, Urquiza J, Ramírez D, Alonso C, Campillo NE, Martinez A. COVID-19: Drug Targets and Potential Treatments. J Med Chem. 2020 Nov 12;63(21):12359–12386. doi: 10.1021/acs.jmedchem.0c00606. Epub 2020 Jun 26. PMID: 32511912; PMCID: PMC7323060. - DOI - PubMed
    1. Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop. 2021 Feb;214 doi: 10.1016/j.actatropica.2020.105778. Epub 2020 Nov 28. PMID: 33253656; PMCID: PMC7695590. - DOI - PMC - PubMed